Luckwel Pharmaceuticals Inc. — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2020)

-$436.0K

Total Assets (FY2020)

$46.7K

Total Equity (FY2020)

-$444.3K

Cash Flows from Operating Activities (FY2020)

-$198.0K

Source: Luckwel Pharmaceuticals Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.